Patents
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
08/2010
08/05/2010US20100197929 Methods of synthesizing pharmaceutical salts of a factor xa inhibitor
08/05/2010US20100197911 Nitrogen-Containing Aromatic Derivatives
08/05/2010US20100197740 Method of Screening Compounds Having Anti-Amyloid Properties
08/05/2010US20100197736 Cetp activity inhibitors
08/05/2010US20100197735 Novel phenylurea inhibitors of the enzyme soat-1 and pharmaceutical/cosmetic compositions comprised thereof
08/05/2010US20100197713 Butone derivatives useful as cooling agents
08/05/2010US20100197655 Sulfonamide derivatives
08/05/2010US20100197652 Pyridine carboxamide orexin receptor antagonists
08/05/2010US20100193774 Quinoid Compounds and Their Use in Semiconducting Matrix Materials, Electronic and Optoelectronic Structural Elements
08/05/2010DE102009006602A1 Alkylamino-substituierte Dicyanopyridine und deren Aminosäureester-Prodrugs Alkylamino-substituted dicyanopyridines and their amino acid ester prodrugs
08/05/2010CA2750967A1 Sulfamoyl-phenyl-ureido benzamidine-derivatives as antimalarial agents
08/05/2010CA2750452A1 N-acyl anthranilic acid derivative or salt thereof
08/05/2010CA2750086A1 Scriptaid isosteres and their use in therapy
08/04/2010EP2213286A1 N-(phenyl or pyridyl)prenylamine derivatives for the treatment of obesity, diabetes and cardiovascular diseases
08/04/2010EP2212292A1 Amides useful as inhibitors of voltage-gated sodium channels
08/04/2010EP2212291A1 Heterocycle phenyl amide t-type calcium channel antagonists
08/04/2010EP2212290A1 Aryl amides useful as inhibitors of voltage-gated sodium channels
08/04/2010EP2212289A1 Method for producing 2,2-difluoroethylamine derivatives by amide hydrogenation
08/04/2010EP2212277A1 Amine linked modulators of y-secretase
08/04/2010EP2211615A1 Pyridosulfonamide derivatives as pi3 kinase inhibitors
08/04/2010EP1670744B1 4-((phenoxyalkyl)thio)-phenoxyacetic aci ds and analogs
08/04/2010EP1392660B1 Substituted benzoylcyclohexenones and their use as herbicidal agents
08/04/2010CN1950362B Process for the preparation of tryptase inhibitors
08/04/2010CN1824662B Substituted pyridine herbicides
08/04/2010CN101796029A Method for electrochemical detection of sequences of nucleic acids
08/04/2010CN101796028A Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors
08/04/2010CN101796026A Guanidine-containing compounds useful as muscarinic receptor antagonists
08/04/2010CN101796019A Structural analogues of avenanthramides, their use in compositions useful in the treatment of dermatological disorders
08/04/2010CN101795674A Tableted compositions containing atazanavir
08/04/2010CN101792432A Pyridine chalcone derivative with aggregation sate fluorescence enhancement and two-photon fluorescence characteristics
08/04/2010CN101792422A Novel organic electroluminescent compounds and organic electroluminescent device using the same
08/04/2010CN101792413A (E)-1-aryl-5-phenyl-2-alkene-1-pentanone compounds and synthesis and application thereof
08/04/2010CN101693687B Method for preparing 2-chloro-N, N-dimethylnicotinamide
08/03/2010US7767706 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
08/03/2010US7767693 inhibition of heat shock protein 90 (HSP90) comprising administering benzoyl compounds or prodrugs,as antitumor agents
08/03/2010US7767650 Ligand activators of the RAR receptors and pharmaceutical/cosmetic applications thereof
08/03/2010US7767626 3-arylphenyl sulfide derivative and insecticide and miticide
08/03/2010US7767624 3-Heterocyclyl substituted benzoic acid derivatives
08/03/2010CA2460654C Crystalline hydrates of nicotinic acid anilide and benzoyl anilide derivatives
07/2010
07/29/2010WO2010084929A1 Process for preparing bisphenol
07/29/2010WO2010084908A1 Organic electroluminescent device
07/29/2010WO2010084852A1 Light-emitting element material and light-emitting element
07/29/2010WO2010084638A1 Method for inhibiting dehydrobromination of methyl 2-bromo-3-[4-[2-(5-ethyl-2-pyridyl)ethoxy]phenyl]propionate
07/29/2010WO2010084160A1 Phenylcyclopropylamine derivatives and their medical use
07/29/2010WO2010065512A3 Compounds for treating proliferative disorders
07/29/2010WO2010011584A3 Process for making a renin inhibitor and related intermediates
07/29/2010WO2009158257A4 Fungicidal pyridines
07/29/2010WO2009153457A3 Novel compounds which have a protective activity with respect to the action of toxins and of viruses with an intracellular mode of action
07/29/2010US20100190993 Biological Buffers with Wide Buffering Ranges
07/29/2010US20100190992 Nicotinamide derivatives as synthesis units for producing agrochemical substances, and method for the production thereof
07/29/2010US20100190991 Synthesis of thiohydantoins
07/29/2010US20100190831 Gpr120 receptor agonists and uses thereof
07/29/2010US20100190795 Betulin derived compounds useful as antiprotozoal agents
07/29/2010US20100190788 Amide derivatives as kinase inhitors
07/29/2010US20100190777 Compounds and methods for kinase modulation, and indications therefor
07/29/2010US20100190766 Antibacterial agents
07/29/2010US20100190764 Novel compounds
07/29/2010US20100190761 Diphenyl substituted alkanes
07/29/2010US20100190753 Methods and Compositions for Treating Amyloid-Related Diseases
07/29/2010US20100190693 Method for screening compounds & uses therefor
07/29/2010US20100187978 Material for organic electro-optical device having fluorene derivative compound and organic electro-optical device including the same
07/29/2010US20100187505 Benzanthracene derivatives for organic electroluminescent devices
07/28/2010EP2210878A1 Therapeutic agent for trpv1-mediated disease
07/28/2010EP2210612A2 Macrocyclic antagonists of the motilin receptor
07/28/2010EP2210597A2 Bacterial virulence modifying agents
07/28/2010EP2209775A1 Heterobicyclic compounds as histamine h4-receptor antagonists
07/28/2010EP2209768A1 5,6-diaryl pyridines substituted in the 2- and 3-position, preparation thereof and therapeutic use thereof
07/28/2010EP2209764A1 Gsm intermediates
07/28/2010EP2209761A1 Diphenyl substituted cycloalkanes
07/28/2010EP2086939B1 Pyridine carboxamides as 11-beta-hsd1 inhibitors
07/28/2010EP1763511B1 Phenoxyacetic acid derivatives as ppar agonists
07/28/2010CN101790517A Inhibitor of binding of s1p1
07/28/2010CN101787016A Pyridine carboxamides as 11-beta-hsd1 inhibitors
07/28/2010CN101786997A Amino acid and pesticide coupling compound as well as preparation method and application thereof as pesticide
07/28/2010CN101786996A Amino acid and pesticide coupling compound as well as preparation method and application thereof as pesticide
07/28/2010CN101786991A Substituted tetracycline compounds
07/28/2010CN101786982A Method for synthetizing 2-pyridyl benzyl cyanide
07/28/2010CN101786975A Lipoamide series derivates, preparation method and pharmaceutical application thereof
07/27/2010US7763747 Bis- and tris-dihydroxyaryl compounds and their methylenedioxy analogs; Alzheimer's disease; diabetes; A beta amyloidosis
07/27/2010US7763659 N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators
07/27/2010US7763640 such as N-methoxy-N'-(2-chloropyrid-5-ylmethyl)nitroguanidine, formed by reacting N-nitro-N'-(2-chloropyrid-5-ylmethyl)-S-methylisothiourea and O-methylhydroxylamine; pesticides; insecticides
07/27/2010US7763618 Pyridyl derivatives and their use as therapeutic agents
07/27/2010CA2436659C Cannabinoid receptor ligands
07/27/2010CA2394611C Process for the preparation of 1,3-disubstituted 2-nitroguanidines
07/22/2010WO2010083441A2 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
07/22/2010WO2010081904A1 4 ( 1h) -pyridinone derivatives and their use as antimalaria agents
07/22/2010WO2010045379A3 Pyridine non-classical cannabinoid compounds and related methods of use
07/22/2010WO2010007046A3 Heteroaryl derivatives as dgat1 inhibitors
07/22/2010US20100184990 Process for the Manufacture of Flecainide
07/22/2010US20100184986 Sulfonamide-based organocatalysts and method for their use
07/22/2010US20100184977 Nickel or Iron Catalysed Carbon-Carbon Coupling Reaction of Arylenes, Alkenes and Alkines
07/22/2010US20100184973 Method for producing dioxazine derivatives
07/22/2010US20100184812 Mutual prodrugs and methods to treat cancer
07/22/2010US20100184787 Heataryl-substituted guanidine compounds and use thereof as binding partners for 5-ht5-receptors
07/22/2010US20100184741 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
07/22/2010US20100183712 Acylated indanyl amines and their use as pharmaceuticals
07/22/2010US20100183606 Monocyclic heterocycles as kinase inhibitors
07/22/2010CA2747835A1 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
07/21/2010EP2208727A1 Diaryl ethers as opioid receptor antagonist
07/21/2010EP2208722A1 Process for production of disulfonic acid compound, asymmetric mannich catalyst, process for production of -aminocarbonyl derivative, and novel disulfonate salt